Kyntra Bio (KYNB) Other Working Capital Changes (2014 - 2026)

Kyntra Bio has disclosed Other Working Capital Changes across 13 years of filings, most recently posting $83000.0 for Q2 2026.

• In Q2 2026, Other Working Capital Changes fell 92.49% year-over-year to $83000.0; the TTM figure through Jun 2026 stood at -$3.0 million (up 90.5% YoY), while the FY2025 annual figure was -$54.1 million, down 447.92% from the prior year.
• Other Working Capital Changes came in at $83000.0 for Q2 2026 at Kyntra Bio, up from -$443000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $22.7 million in Q2 2022 to a low of -$143.9 million in Q3 2025.
• Average Other Working Capital Changes over 5 years is -$10.8 million, with a median of -$5.9 million recorded in 2022.
• The largest YoY upside for Other Working Capital Changes was 2268.22% in 2023 against a maximum downside of 2193.93% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$8.0 million in 2022, then jumped by 109.66% to $772000.0 in 2023, then slumped by 440.8% to -$2.6 million in 2024, then soared by 125.54% to $672000.0 in 2025, then plunged by 87.65% to $83000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $83000.0 in Q2 2026, -$443000.0 in Q1 2026, and $672000.0 in Q4 2025.